Aim: This study aims to evaluate the views of the adult male population in Turkey concerning the use of drugs (Phosphodiesterase type 5 inhibitors) and herbal products to increase sexual performance, and to assess the use and outcomes of these medications within the study site. Material and Method: This non-interventional, observational, sectional site study was conducted in 2012. Participants were randomly selected from 19 provinces of Turkey according to Eurostat and Nomenclature of territorial units for statistics (NUTS) Level-2 by a proportional sampling method according to postal code lists. Men aged 18 years or older were included in this study as representatives of the male Turkish population. Of these, 410 men using at least one ere...
A randomised, double-blind, parallel, placebo-controlled, 12-week study was carried out to evaluate ...
Background: Erectile dysfunction (ED) is a major health concern which in some communities has been e...
Sildenafil is one of two oral drugs approved for first-line treatment of erectile dysfunction (ED). ...
WOS: 000320618100004PubMed ID: 23785019Udenafil is a potent phosphodiesterase type-5 inhibitor (PDE5...
Sexual beliefs underlying male sexual dysfunction are known to emphasize excessively high sexual per...
Objective: The aim of this study is to investigate trends in women's perception of male erectile dys...
The pharmaceutically focused clinical and epidemiological literature on erectile dysfunction (ED) tr...
Aim: Use of erectile dysfunction medications (EDMs) is relatively common among gay and bisexual men ...
An aphrodisiac is defined as a drug that arouses sexual instinct, induces venereal desire and increa...
The impact of erectile dysfunction is distressing to both males and their female partners, but less ...
Introduction: Erectile dysfunction (ED) is a multidimensional disorder with an estimated prevalence ...
Introduction: Several preference studies comparing a short-acting with a longer-acting phosphodieste...
The impact of erectile dysfunction is distressing to both males and their female partners, but less ...
Introduction: Management of erectile dysfunction (ED) is beset with assumptions around spontaneity o...
The immediate objective of phosphodiesterase type 5 (PDE5) inhibitor treatment is to restore the abi...
A randomised, double-blind, parallel, placebo-controlled, 12-week study was carried out to evaluate ...
Background: Erectile dysfunction (ED) is a major health concern which in some communities has been e...
Sildenafil is one of two oral drugs approved for first-line treatment of erectile dysfunction (ED). ...
WOS: 000320618100004PubMed ID: 23785019Udenafil is a potent phosphodiesterase type-5 inhibitor (PDE5...
Sexual beliefs underlying male sexual dysfunction are known to emphasize excessively high sexual per...
Objective: The aim of this study is to investigate trends in women's perception of male erectile dys...
The pharmaceutically focused clinical and epidemiological literature on erectile dysfunction (ED) tr...
Aim: Use of erectile dysfunction medications (EDMs) is relatively common among gay and bisexual men ...
An aphrodisiac is defined as a drug that arouses sexual instinct, induces venereal desire and increa...
The impact of erectile dysfunction is distressing to both males and their female partners, but less ...
Introduction: Erectile dysfunction (ED) is a multidimensional disorder with an estimated prevalence ...
Introduction: Several preference studies comparing a short-acting with a longer-acting phosphodieste...
The impact of erectile dysfunction is distressing to both males and their female partners, but less ...
Introduction: Management of erectile dysfunction (ED) is beset with assumptions around spontaneity o...
The immediate objective of phosphodiesterase type 5 (PDE5) inhibitor treatment is to restore the abi...
A randomised, double-blind, parallel, placebo-controlled, 12-week study was carried out to evaluate ...
Background: Erectile dysfunction (ED) is a major health concern which in some communities has been e...
Sildenafil is one of two oral drugs approved for first-line treatment of erectile dysfunction (ED). ...